Christopher Griffith - Dermira Insider

DERM -- USA Stock  

USD 10.07  0.18  1.76%

Co-Founder and VP of Corporate Devel. and Strategy
Mr. Christopher M. Griffith is Senior Vice President Corporationrationrate Development and Strategy, Founder of the Company. He founded our company in August 2010 and has served as our senior vice president of corporate development and strategy since January 2017, after previously serving as our vice president of corporate development and strategy since August 2011 and head of corporate development and strategy since September 2010. From July 2005 to September 2010, Mr. Griffith worked in corporate development at Gilead Sciences, Inc. From May 2004 to August 2004, Mr. Griffith worked in the biooncology strategy group at Genentech, Inc., a biotechnology company. From 2001 to 2003, Mr. Griffith worked at Bay City Capital
Age: 40  Founder Since 2017  MBA    
650-421-7200  http://www.dermira.com
Griffith received B.S. and M.S. degrees in biological sciences from Stanford University and an M.B.A. degree from Harvard Business School.

Christopher Griffith Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (25.67) % which means that it has lost $25.67 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (124.96) % meaning that it created substantial loss on money invested by shareholders.
The company currently holds 279.85 M in liabilities with Debt to Equity (D/E) ratio of 218.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Dermira has Current Ratio of 5.07 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

Dermira, Inc., a biopharmaceutical company, identifies, develops, and commercializes therapies to treat dermatologic diseases. Dermira, Inc. was founded in 2010 and is headquartered in Menlo Park, California. Dermira operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 162 people.Dermira (DERM) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 162 people. Dermira is listed under Pharmaceutical Products category by Fama And French industry classification.

Dermira Leadership Team

Jake Nunn, Director, CFA
Frederick Craves, Director
William Young, Chairman
Ian Clements, Executive
Lori LyonsWilliams, Executive, MBA
Christopher Griffith, Founder, MBA
Matthew Fust, Director, MBA
David Cohen, Director
Kathleen Sebelius, Director
Mark McDade, Director, MBA
Emmanuel Caeymaex, Director
Christopher Horan, Executive
William Ringo, Director, MBA
Luis Pena, Founder
Thomas Wiggans, Chairman, MBA
Eugene Bauer, Director
Andrew Guggenhime, COO, MBA

Stock Performance Indicators

Did you try this?

Run Fundamentals Matrix Now
   

Fundamentals Matrix

View fundamentals matrix and analyze how accounts are interrelated and interconnected with each other
All  Next Launch Fundamentals Matrix

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Dermira and China Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.